Evaxion Biotech Extends Phase 2 Trial for Cancer Vaccine EVX-01

TipRanksFeb 25 08:47 ET

Express News | Evaxion Biotech A/S: Trial Has Been Extended by an Additional Year to Collect Three-Year Clinical Outcome Data

ReutersFeb 25 08:00 ET

Express News | Evaxion Extends Phase 2 Trial With Personalized Cancer Vaccine Evx-01 to Further Enhance Clinical Data Package

ReutersFeb 25 08:00 ET

Evaxion Extends Phase 2 Trial With Personalized Cancer Vaccine EVX-01 to Further Enhance Clinical Data Package

GlobeNewswireFeb 25 08:00 ET

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT NewswiresFeb 24 11:04 ET

Evaxion Biotech Analyst Ratings

BenzingaFeb 20 06:57 ET · Ratings